share_log

藥明康德:翌日披露報表

WUXI APPTEC: Next Day Disclosure Return

HKEX ·  Sep 11, 2024 18:21

Summary by Moomoo AI

無錫藥明康德新藥開發股份有限公司於2024年9月11日實施股份回購計劃,根據香港聯合交易所有限公司主板上市規則第13.25A條及GEM上市規則第17.27A條的要求,公司回購了522,300股A類普通股。該次股份回購的交易價格範圍為每股人民幣37.37元至38.67元,總交易金額達到人民幣20,007,654元。回購的股份將擬註銷,並且在回購後的30天內,公司將不會發行新股或出售或轉讓任何庫存股份。此次股份回購行動已獲得公司董事會的正式授權並遵守相關法律及監管規定。股份回購後,公司的已發行股份總數維持不變為2,524,851,053股。
無錫藥明康德新藥開發股份有限公司於2024年9月11日實施股份回購計劃,根據香港聯合交易所有限公司主板上市規則第13.25A條及GEM上市規則第17.27A條的要求,公司回購了522,300股A類普通股。該次股份回購的交易價格範圍為每股人民幣37.37元至38.67元,總交易金額達到人民幣20,007,654元。回購的股份將擬註銷,並且在回購後的30天內,公司將不會發行新股或出售或轉讓任何庫存股份。此次股份回購行動已獲得公司董事會的正式授權並遵守相關法律及監管規定。股份回購後,公司的已發行股份總數維持不變為2,524,851,053股。
Wuxi Apptec implemented a share repurchase plan on September 11, 2024, in accordance with the requirements of Rule 13.25A of the Listing Rules of the Main Board of the Hong Kong Stock Exchange and Rule 17.27A of the GEM Listing Rules. The company repurchased 522,300 shares of Class A ordinary shares. The trading price range for the share repurchase was RMB 37.37 to 38.67 per share, with a total transaction amount of RMB 20,007,654. The repurchased shares will be proposed for cancellation, and within 30 days after the repurchase, the company will not issue new shares or sell or transfer any treasury shares. This share repurchase action has obtained formal authorization from the company's board of directors and complies with relevant laws and regulations. After the share repurchase, the total number of issued shares of the company remains unchanged at 2,524,851,053 shares.
Wuxi Apptec implemented a share repurchase plan on September 11, 2024, in accordance with the requirements of Rule 13.25A of the Listing Rules of the Main Board of the Hong Kong Stock Exchange and Rule 17.27A of the GEM Listing Rules. The company repurchased 522,300 shares of Class A ordinary shares. The trading price range for the share repurchase was RMB 37.37 to 38.67 per share, with a total transaction amount of RMB 20,007,654. The repurchased shares will be proposed for cancellation, and within 30 days after the repurchase, the company will not issue new shares or sell or transfer any treasury shares. This share repurchase action has obtained formal authorization from the company's board of directors and complies with relevant laws and regulations. After the share repurchase, the total number of issued shares of the company remains unchanged at 2,524,851,053 shares.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more